Q2 2018 Holdings
Filed 2018-08-13 | 25 holdings | $568.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $534.0K | 5,425 | 94.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $6.5K | 107,434 | 1.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $3.1K | 76,836 | 0.5% |
| Mylan N V | SHS EURO | N59465109 | $3.0K | 83,370 | 0.5% |
| Cigna Corporation | COM | 125509109 | $3.0K | 17,392 | 0.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $2.5K | 71,400 | 0.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $1.8K | 5,220 | 0.3% |
| Radius Health Inc | COM NEW | 750469207 | $1.8K | 60,521 | 0.3% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $1.6K | 22,300 | 0.3% |
| CVS Health Corp(CVS) | COM | 126650100 | $1.6K | 24,330 | 0.3% |
| Allergan PLC | SHS | G0177J108 | $1.5K | 8,723 | 0.3% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $1.4K | 85,558 | 0.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $1.1K | 15,970 | 0.2% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $1.0K | 7,500 | 0.2% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $621 | 27,397 | 0.1% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $543 | 85,050 | 0.1% |
| Endologix Inc | COM | 29266S106 | $517 | 91,422 | 0.1% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $502 | 29,821 | 0.1% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $485 | 11,123 | 0.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $415 | 31,594 | 0.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $412 | 61,304 | 0.1% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $338 | 67,429 | 0.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $297 | 2,625 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $249 | 17,090 | 0.0% |
| Mylan N VCall | SHS EURO | N59465109 | $1 | 2,125 | 0.0% |